Discover
NSRX
Nasus Pharma Ltd.
3.52
100 x 3.46
200 x undefined
bid
ask
+
0.02
0.43%
150 @ 07:00 AM
3.51 -0.01 (0.14%)
| Ytd | -61.58% | |
| 1y | -57.39% |
3.50
day range
3.53
1.98
52 week range
9.99
| Open | 3.58 | Prev Close | 3.50 | Low | 3.50 | High | 3.53 | Mkt Cap | 41.16M |
| Vol | 2.58K | Avg Vol | 70.00K | EPS | -0.72 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 3.09 | 200-d Avg | 5.32 | 1yr Est | 0.00 |
| Income Statement | |||
| Weighted Average Shares | 8.01M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.29M | ||
| Cash and Equivalents (USD) | 1.29M | ||
| Investments | 3.05M | ||
| Investments Current | 3.05M | ||
| Current Assets | 4.86M | ||
| Property, Plant & Equipment Net | 149.00K | ||
| Total Assets | 5.00M | ||
| Debt Current | 45.00K | ||
| Total Debt | 118.00K | ||
| Current Liabilities | 2.16M | ||
| Debt Non-Current | 73.00K | ||
| Total Liabilities | 2.24M | ||
| Accumulated Retained Earnings (Deficit) | -18.52M | ||
| Shareholders Equity | 2.77M | ||
| Shareholders Equity (USD) | 2.77M | ||
| Assets Non-Current | 149.00K | ||
| Total Debt (USD) | 118.00K | ||
| Liabilities Non-Current | 73.00K | ||
| Trade and Non-Trade Payables | 829.00K | ||